11 – 20 of 69
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy
(2020) In Proceedings of the National Academy of Sciences of the United States of America 117(26). p.15172-15181
- Contribution to journal › Article
-
Mark
Preclinical Single Photon Emission Computed Tomography of Alpha Particle-Emitting Radium-223
- Contribution to journal › Article
- 2019
-
Mark
Harnessing androgen receptor pathway activation for targeted alpha particle radioimmunotherapy of breast cancer
- Contribution to journal › Article
-
Mark
Kallikrein markers performance in pretreatment blood to predict early prostate cancer recurrence and metastasis after radical prostatectomy among very high-risk men
(2019) In Prostate
- Contribution to journal › Article
-
Mark
Preclinical efficacy of hK2 targeted [177Lu]hu11B6 for prostate cancer theranostics
- Contribution to journal › Article
- 2018
-
Mark
Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age : Data from the malmö preventive project
- Contribution to journal › Article
-
Mark
Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival
- Contribution to journal › Article
-
Mark
Association Between Lead Time and Prostate Cancer Grade : Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening
- Contribution to journal › Article
-
Mark
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
- Contribution to journal › Article
-
Mark
Twenty-year Risk of Prostate Cancer Death by Midlife Prostate-specific Antigen and a Panel of Four Kallikrein Markers in a Large Population-based Cohort of Healthy Men
- Contribution to journal › Article
